FOETAL MEGACYSTIS

FOETAL MEGACYSTIS was reported 44 times

FOETAL MEGACYSTIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 7 0.0024
1 General Anesthetic [EPC] 3 0.0001
2 Opioid Agonist [EPC] 13 0.0000
3 Protease Inhibitor [EPC] 2 0.0000
4 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
5 Nitroimidazole Antimicrobial [EPC] 1 0.0000
6 Mood Stabilizer [EPC] 2 0.0000
7 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
8 Vitamin D [EPC] 2 0.0000
9 Vitamin B12 [EPC] 2 0.0000
10 Vitamin C [EPC] 2 0.0000
11 Anti-epileptic Agent [EPC] 1 0.0000
12 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
14 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000